[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease (Q44060156)

29 November 2017

[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease (English)

1 reference

29 November 2017

1 reference

parkinsonian syndrome

1 reference

4

Bastiaan R Bloem

1 reference

29 November 2017

Willibald Gerschlager

1

1 reference

29 November 2017

Gerhard Bencsits

2

1 reference

29 November 2017

Walter Pirker

3

1 reference

29 November 2017

Susanne Asenbaum

5

1 reference

29 November 2017

Daniella Prayer

6

1 reference

29 November 2017

Jan C M Zijlmans

7

1 reference

29 November 2017

Martha Hoffmann

8

1 reference

29 November 2017

Thomas Brücke

9

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

29 November 2017

1 reference

29 November 2017

17

1 reference

29 November 2017

3

1 reference

29 November 2017

518-523

1 reference

Lacunar strokes and infarcts: a review

29 November 2017

1 reference

Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study.

21 January 2018

1 reference

Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease.

21 January 2018

1 reference

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

Parkinsonism due to a basal ganglia lacunar state: clinicopathologic correlation.

21 January 2018

1 reference

Basal ganglia lacunes and parkinsonism.

21 January 2018

1 reference

[123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain.

21 January 2018

1 reference

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

21 January 2018

1 reference

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

21 January 2018

1 reference

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

21 January 2018

1 reference

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.

21 January 2018

1 reference

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

21 January 2018

1 reference

SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain

21 January 2018

1 reference

Lower body parkinsonism: evidence for vascular etiology

21 January 2018

1 reference

Clinical correlates of vascular parkinsonism

21 January 2018

1 reference

MRI in patients with suspected vascular parkinsonism

21 January 2018

1 reference

Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases

21 January 2018

1 reference

Hydrocephalus as a cause of disturbances of gait in the elderly

21 January 2018

1 reference

[3H]GBR 12935 binding to dopamine uptake sites in the human brain

21 January 2018

1 reference

Secondary parkinsonism due to focal substantia nigra lesions: a PET study with [18F]FDG and [18F]fluorodopa

21 January 2018

1 reference

Progressive supranuclear palsy and a multi-infarct state

21 January 2018

1 reference

Urinary and gait disturbances as markers for early multi-infarct dementia

21 January 2018

1 reference

A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.10092

1 reference

29 November 2017

1 reference